Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer
{{output}}
In 1960s, cromolyn sodium (CS) has been introduced as the first non-steroidal anti-inflammatory drug for the treatment of allergic and mast-cell driven diseases. Its applicability has been limited due to a poor bioavailability. Here we present pharmacokinetic ... ...
